10 sonuç
📅 2016 🏆 Q3 📈 SJR ≥ 0,5
Excel'e Aktar
Scopus
🏆 Q3 · SJR 0,502 YÖKSİS Eşleşti
Effects of coenzyme q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients: A double-blind placebo-controlled crossover trial
· Cilt 23, s.e1736-e1743
Scopus
🏆 Q3 · SJR 0,502 YÖKSİS Eşleşti
Effects of coenzyme q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients: A double-blind placebo-controlled crossover trial
· Cilt 23, s.e1736-e1743
Scopus
🏆 Q3 · SJR 0,502 YÖKSİS Eşleşti
Safety, feasibility, and efficacy of capecitabine maintenance in patients with advanced gastric cancer: A retrospective study
· Cilt 23, s.e1493-e1497
Scopus
🏆 Q3 · SJR 0,636 YÖKSİS Eşleşti
The evaluation of possible role of endocrine disruptors in central and peripheral precocious puberty
· Cilt 26, s.493-500
Scopus
🏆 Q3 · SJR 0,584 YÖKSİS Eşleşti
Tannic acid inhibits proliferation, migration, invasion of prostate cancer and modulates drug metabolizing and antioxidant enzymes
· Cilt 16, s.781-789
Scopus
🏆 Q3 · SJR 0,581 YÖKSİS Eşleşti
Is there any potential or additive effect of anemia on hepatorenal syndrome?
· Cilt 27, s.273-278
Scopus
🏆 Q3 · SJR 0,581 YÖKSİS Eşleşti
KDIGO (Kidney Disease: Improving Global Outcomes) criteria as a predictor of hospital mortality in cirrhotic patients
· Cilt 27, s.173-179
Scopus
🏆 Q3 · SJR 0,502 YÖKSİS Eşleşti
Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine
· Cilt 23, s.e68-e73
Scopus
🏆 Q3 · SJR 0,502 YÖKSİS Eşleşti
Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine
· Cilt 23, s.e68-e73
Scopus
🏆 Q3 · SJR 0,502
Sigmoid Colon Perforation Related to Bevacizumab in a Patient with Glioblastoma
· Cilt 23, s.e241-e242